A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue

NCT01855997 · clinicaltrials.gov ↗

COMPLETED

Status

1669

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Peg-IFN alfa-2a

Sponsor

Hoffmann-La Roche